[1]ChemicalBiologyandDrugDesign,2013,vol.81,p.715-729
[2]Lettersindrugdesignanddiscovery,2020,vol.17,p.145-154
1215738-09-2
245547-16-4 | 3-(1-Methyl-1H-imidazol-2-yl)aniline | AA002OFU | MFCD09035978
2463-45-8 | 1,3-Dioxolan-2-one,4-(chloromethyl)- | AA002OSN | MFCD00022483
247129-88-0 | Diphenylvinylsulfonium triflate | AA002P36 | MFCD22123284
247940-06-3 | 2-(Dicyclohexylphosphino)biphenyl | AA002PDP | MFCD01862441
24892-81-7 | 1-Chloro-2-(1-phenyl-vinyl)-benzene | AA002POV | MFCD06658408
2498-41-1 | 5-Methyl-2'-deoxycytidine 5'-monophosphate | AA002Q03 | MFCD00038064
25084-14-4 | 2-Furancarbonyl chloride, 5-nitro- | AA002QDA | MFCD00039564
25168-73-4 | α-D-Glucopyranoside, β-D-fructofuranosyl, monooctadecanoate | AA002QNG | MFCD00152822
2591-92-6 | 1,4-Methanonaphthalene-5,8-dione, 1,2,3,4,9,9-hexachloro-1,4,4a,8a-tetrahydro- | AA002QXB | MFCD00213578
25981-83-3 | 5-Chloro-2,3,3-trimethyl-3H-indole | AA002R83 | MFCD00126966